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models for the regulatory networks controlling flagellar p53-Mediated Transcriptional
biosynthesis in other bacteria such as Salmonella, which Activation: From Test Tube to Cellhave a network architecture similar to the E. coli system
(Aldridge and Hughes, 2002). Comparative analysis of
these models could then elucidate how variability in
network behavior is connected to the variability in the Posttranslational modifications of histones have been
network structure and parameters of the model. strongly correlated with transcriptional regulation. In
The work by Kalir and Alon (2004) builds on efforts this issue of Cell, An et al. (2004) comprehensively
to reconstruct transcriptional regulatory networks on a examined the nature of arginine methyltransferases and
qualitative level, i.e., obtaining the connectivity dia- histone modifications in p53-mediated transcription.
grams through high-throughput technologies such as
expression profiling and location analysis (Covert et al., The N and C termini, or tails, of histones provide sites
2004; Lee et al., 2002). The remarkable aspect of this for posttranslational modifications, such as phosphory-
work is that the experimental methods are widely used lation, acetylation, methylation, and ubiquitination. Many
and can be readily extended to most model organisms. studies have demonstrated that modifications of these
In principle this makes it possible to build detailed mod- tails correlate with both gene activation and repression
els of any transcriptional regulatory network whose con- (Zhang and Reinberg, 2001). In particular, the histone
nectivity is known. On a more cautious note, while one arginine methyltransferases CARM1 and PRMT1 are un-
may be able to build these models for subnetworks, der intense study because of their coactivator role in
they may not accurately represent the behavior of these nuclear hormone-mediated transcription (Chen et al.,
networks in the context of the whole cell. For example, 1999). These enzymes specifically methylate histone H3
the model proposed by Kalir and Alon (2004) does not at Arg2, Arg17, and Arg26, and histone H4 at Arg3, re-
explicitly include the regulatory processes leading to spectively. Both CARM1 and PRMT1 act in concert with
the activation of the FlhDC regulator (Lehnen et al., 2002) the acetyltransferase CBP/p300, along with the p160
or the negative feedback regulation of FliA by FlgM coactivator family to enhance transcription from hor-
(Neidhardt, 1996). To complement the small scale in mone-responsive promoters (Stallcup, 2001). The tumor
silico models, such as the flagellar biosynthesis network suppressor protein, p53, also utilizes CBP/p300 for tran-
model presented here, there is also need to build models scription activation (Gu et al., 1997; Lill et al., 1997),
of entire cells or at least subsystems such as metabolism thus, raising the question: do other coactivators, such
or transcriptional regulation as a whole (Covert et al., as arginine methyltransferases, play a key role p53-
2004). mediated transcription?
Although many groundbreaking studies correlate his-
tone modifications, such as methylation or acetylation,Markus J. Herrga˚rd and Bernhard Ø. Palsson
with transcriptional activation of nuclear hormone andDepartment of Bioengineering
p53-regulated genes, little has been done to test theUniversity of California, San Diego
direct role of these modifications in transcriptional acti-9500 Gilman Drive
vation. Furthermore, several studies have demonstratedLa Jolla, California 92093
that these coactivators can also modify other proteins
Selected Reading (Xu et al., 2001; Chevillard-Briet et al., 2002). Therefore,
are histones the relevant target substrates for these
Aldridge, P., and Hughes, K.T. (2002). Curr. Opin. Microbiol. 5, coactivators? Do histone modifications play a direct role
160–165.
in transcription? In this issue of Cell, An et al. (2004) get
Covert, M.W., Knight, E.M., Reed, J.L., Herrgard, M.J., and Palsson, to the very nature of these questions.
B.O. (2004). Nature 429, 92–96.
Many studies have characterized histone-modifying
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enzymes such as histone acetyltransferases and meth-Leibler, S., Surette, M.G., and Alon, U. (2001). Science 292, 2080–
yltransferases utilizing either recombinant histones or2083.
bulk cellular nucleosomes as substrates. An et al. (2004)Kalir, S., and Alon, U. (2004). Cell 117, this issue, 713–719.
utilized the benefits of both substrates by creating re-Lee, T.I., Rinaldi, N.J., Robert, F., Odom, D.T., Bar-Joseph, Z.,
combinant chromatin templates. These templates wereGerber, G.K., Hannett, N.M., Harbison, C.T., Thompson, C.M., Si-
mon, I., et al. (2002). Science 298, 799–804. unique in that they contained p53 DNA binding sites and
were formed with either recombinant wild-type histonesLehnen, D., Blumer, C., Polen, T., Wackwitz, B., Wendisch, V.F., and
Unden, G. (2002). Mol. Microbiol. 45, 521–532. or histones that were either lacking tails or mutated at
Neidhardt, F.C. ed. (1996). Escherichia coli and Salmonella: Cellular critical lysine or arginine residues that are targets of
and Molecular Biology, 2nd ed. (Washington, D.C.: ASM Press). these methyltransferases. The advantage of this assay
Ronen, M., Rosenberg, R., Shraiman, B.I., and Alon, U. (2002). Proc. system is that it allows monitoring of histone modifica-
Natl. Acad. Sci. USA 99, 10555–10560. tions and serves as a template for in vitro transcription.
Setty, Y., Mayo, A.E., Surette, M.G., and Alon, U. (2003). Proc. Natl. Thus, this system provides a direct way to observe the
Acad. Sci. USA 100, 7702–7707. result of histone modifications on transcription.
Shen-Orr, S.S., Milo, R., Mangan, S., and Alon, U. (2002). Nat. Genet. Using this assay, An et al. (2004) first determined that
31, 64–68. CARM1, PRMT1, and p300 are required by p53 to modify
the histones in the chromatin template. In addition, p53-
dependent transcription was increased significantly by
the presence of all three coactivators. Mutations at the
Previews
691
target lysine and arginine residues significantly reduced H3 Lys4 methylation was also dependent on the N termi-
transcriptional activation by CARM1 and p300, but not nus of p53, suggesting yet another coactivator involved
PRMT1. Curiously, p53-dependent transcriptional acti- in p53-mediated transcription. Possible candidates for
vation stimulated by PRMT1 is not significantly de- this activity could be the SET domain Lys4 methyltrans-
creased when its main target methylation site on H4 is ferases Set9 and MLL. Or will a novel p53-associated
mutated. However, upon further analysis An et al. (2004) SET domain methyltransferase be discovered?
found that PRMT1 was also involved in methylation of To complete their study An et al. (2004) demonstrated
H2A. Mutation of the PRMT1 arginine methylation sites the accumulation of endogenous p53 and its coactiva-
within both H4 and H2A caused a complete loss of tran- tors at the p53-responsive gene, GADD45, in vivo, at
scriptional activation, revealing a functional redundancy various time points after UV exposure. Within two hours
in the histones tails and demonstrating the importance after exposure the levels of p53 and p300 binding to the
of maintaining these modifications for transcription. p53 response element reached their peak, and were
These results provide compelling evidence that the his- soon followed by the appearance CARM1 binding to
tones are relevant targets for CARM1, PRMT1, and p300 the site. H4 Arg3 methylation, presumably by PRMT1,
and that the resulting histone modifications are directly appeared concurrently with p300. These data not only
important for transcription. support the elegant in vitro and in vivo studies performed
Because CARM1, PRMT1, and p300 were recombi- by An et al. (2004), but also characterizes the stepwise
nantly purified, An et al. (2004) were also able to address association and activities of these coactivators in a p53-
cooperative effects of these coactivators on histone mediated pathway.
acetylation and methylation by controlling the order of This comprehensive and thorough study presented
coactivator addition. For example, it has been previously by An et al. (2004), provides new insights into coactivator
shown that H4 Arg3 methylation by PRMT1 prefers un- regulation occurring at a p53 promoter, the obligatory
acetylated histone tails, and that H3 Arg17 methylation role of histone modifications in transcription, and novel
by CARM1 prefers acetylated histone tails (Wang et al., coactivator interactions with p53. Once thought to solely
2001; Daujat et al., 2002). An et al. (2004) showed that play a role in nuclear hormone receptor-mediated re-
preincubation of a chromatin template with p53 and sponse, An et al. (2004) provide compelling new evi-
PRMT1 significantly stimulated the histone acetyltrans- dence that the protein arginine methyltransferases
ferase activity of p300 and, similarly, that preincubation CARM1 and PRMT1 act as coactivators for p53-medi-
of the template with p53 and p300-stimulated H3 argi- ated transcriptional activation, via direct interactions
nine methylation by CARM1. Furthermore, cooperative with p53 and its associated coactivator partner p300.
effects of these coactivators on p53-dependent tran- This novel work presents us with yet another pathway,
scription were also observed. In vitro, p53-mediated which is regulated by histone methylation. With the in-
transcription was stimulated the greatest when all three creasing interest in histone methylation as a mechanism
coactivators were present, whether added sequentially for gene regulation, we will undoubtedly discover other
or at the same time. These findings were similar to what exciting roles for methyltransferases and the cellular
has been observed between CARM1, PRMT1, p300, and processes that they direct.
members of the p160 family of coactivators in nuclear
receptor-mediated transcription.
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